Diagnos Inc.
TSX VENTURE : ADK

Diagnos Inc.

April 22, 2009 10:38 ET

DIAGNOS and its Partner Hitlab ULC Features Dynamic Hit Scoring (DHS) Technology on Hitlab.com

BROSSARD, QUEBEC, CANADA--(Marketwire - April 22, 2009) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces today that its partner Hitlab ULC successfully launched Hitlab.com, last March 23, which features Dynamic Hit Scoring (DHS) developed by DIAGNOS.

DHS is a technology that can predict if a song has the potential to become a hit. DHS breaks down a song into variables such as pitch, tempo, etc. and compares its structure to the top 100 Billboard ® charts of the past six years. The more the song's patterns resemble the ones of hits, the higher it scores. Recently Hitlab.com and world renowned Hip Hop singer, song-writer and record producer Akon have teamed up to promote and showcase this technology on www.hitlab.com.

The marketing success of the Hitlab web site is directly related to the importance it will receive on the internet. Since the launch of the new web site, traffic has increased significantly, going from 50 visitors per day to 5,000 visitors per day. DIAGNOS believes that with the support of an artist such as AKON, the traffic generated on the site will grow. DIAGNOS receives a $3.00 royalty for each song analysed on this web site. "We are very exited by this news and we are looking forward to see more results, said Andre Larente, President DIAGNOS."

About DIAGNOS

DIAGNOS can count on a multidisciplinary team that includes professionals in geophysics, geology, artificial intelligence, mathematics, information technology, as well as remote sensing and image interpretation.

About Hitlab.com

Hitlab.com is an online lab where musicians can come and test out their songs to find out if they have a potential hit on their hands. Hitlab uses revolutionary DHS technology (Dynamic Hit Scoring) built by DIAGNOS, which compares song's hit potential to the Top 100 Billboard® hits of the past 6 years. Hitlab has applied for patents in Canada, the United States of America and with the PCT (Patent Cooperation Treaty-188 country coverage).

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information

  • DIAGNOS inc.
    Andre Larente
    Chairman and CEO
    1-877-678-8882 or 450-678-8882, ext. 224
    alarente@diagnos.com